THE LEADING RESEARCH REPORTS DISTRIBUTION
NETWORK

icrowd research icrowd research icrowd research icrowd research icrowd research icrowd research icrowd research icrowd research

The Next 10 Years To See A Running Trend For Organic Expansion Of Peripherally Inserted Central Catheters Market (US$ 1058.6 Million)

Sep 15, 2021 7:55 PM ET

The Next 10 Years To See A Running Trend For Organic Expansion Of Peripherally Inserted Central Catheters Market (US$ 1058.6 Million)

The Peripherally Inserted Central Catheters Market is bound to reach US$ 1058.6 Million at a CAGR of 5.8% between 2024. The modern-day situation says that the healthcare sector is witnessing an optimization and reposition of the business models to obtain enhanced patient outcomes. With real-time analytics known to improve patient care and the fact that consumers are shifting towards the preventive model of care, the healthcare vertical is likely to witness greater strides in the forecast period.

Persistence Market Research delivers key insights on the global peripherally inserted central catheters market in its published report titled “Global Market Study on Peripherally Inserted Central Catheters: Power Injected Peripherally Inserted Central Catheters Product Type Segment to Dominate the Market Through 2024 .” The global peripherally inserted central catheters market is anticipated to reach a market valuation of US$ 673.9 Mn by the end of 2016.

Peripherally inserted central catheters constitute a single subtype of catheters that are specifically used for IV administration especially for continuous therapy ranging from more than a week to less than five weeks. The indications for peripherally inserted central catheters include chemotherapy drugs, parenteral nutrition, blood sample withdrawal, and many more.

In terms of revenue, the global peripherally inserted central catheters market is projected to register a healthy CAGR of 5.8% over the forecast period (2016 – 2024) owing to various factors, regarding which Persistence Market Research offers vital insights in detail.

Want Insights To Peripherally Inserted Central Catheters Market? Ask For Sample! https://www.persistencemarketresearch.co/samples/12316

Company Profiles 

  • Global Players
  • AngioDynamic, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • C. R. Bard, Inc.
  • Teleflex Incorporated
  • Argon Medical Devices, Inc.
  • Boston Scientific Corporation
  • COOK MEDICAL INC.
  • ICU Medical Inc.
  • Medical Components, Inc.
  • Medtronic, Inc
  • Navilyst Medical, Inc.
  • Vygon (UK) Ltd

Planning To Conclude Your Strategy On A Decisive Note In The Peripherally Inserted Central Catheters Market? Glance Through The “Methodology” Implied! https://www.persistencemarketresearch.co/methodology/12316

Market dynamics

Increasing healthcare expenditure, robust reimbursement policies, increasing preference for peripherally inserted central catheters by healthcare physicians, and increasing number of diseases requiring the application of peripherally inserted central catheters are some of the factors likely to boost the growth of the global peripherally inserted central catheters market over the forecast period.

However, factors such as increasing usage of midline catheters, lack of specialized professionals for catheterization, and high risk of bloodstream infections and deep vein thrombosis are likely to restrict market growth. Technological advancements in peripherally inserted central catheters and recent demand based innovations such as the introduction of anti-microbial peripherally inserted central catheters and anti-thrombogenic peripherally inserted central catheters will define the future landscape of the global peripherally inserted central catheters market.

Market forecast

The global peripherally inserted central catheters market is segmented on the basis of Product (Power Injected Peripherally Inserted Central Catheters, Conventional Peripherally Inserted Central Catheters); Design (Single Lumen, Double Lumen, Multiple Lumen); End User (Hospitals, Ambulatory Surgical Centers, Catheterization Laboratories); and Region (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa).

The Power Injected Peripherally Inserted Central Catheters product type segment dominated the global peripherally inserted central catheters market in revenue terms, accounting for 82.2% value share in 2015 and is expected to continue to do so throughout the forecast period. This segment is expected to grow with a healthy CAGR over the forecast period, owing to high adoption rate of newly launched products and better reimbursement policies.

The Multiple Lumen design segment is anticipated to account for 59.7% revenue share of the global peripherally inserted central catheters market by 2016 end. This segment is expected to expand at a CAGR of 6.7% over the forecast period due to increase in the number of cancer patients requiring multiple lumen peripherally inserted central catheters for better treatment. The Hospitals end user segment accounted for 68.3% value share in 2015 and is projected to account for 72.0% share by 2024 end.

How About Knowing The Product/Technology Driving The Peripherally Inserted Central Catheters Market Before Investing Therein? Click The “Purchase Now” Button Of Our Peripherally Inserted Central Catheters Market Report! https://www.persistencemarketresearch.com/checkout/12316

Among regions, North America dominated the global peripherally inserted central catheters market in revenue terms in 2015 and is expected to continue to do so throughout the forecast period. The North America peripherally inserted central catheters market is estimated to create absolute $ opportunity of US$ 19.8 Mn in 2017 over 2016.

North America and Europe are expected to account for 81.5% and 10.5% share respectively of the global peripherally inserted central catheters market in terms of value in 2016. Among emerging markets, Asia Pacific is estimated to exhibit a CAGR of 11.2% over the forecast period.

Access Trending Reports:

Adult Hemoglobinopathy Testing Market – In terms of revenue, during the forecast period 2018-2026, the global adult hemoglobinopathy testing market is anticipated to reach a valuation of US$ 420.3 Mn by 2026, expanding at a moderate 3.9% CAGR.

Progressive Multifocal Leukoencephalopathy Treatment Market – The global progressive multifocal leukoencephalopathy treatment market is expected to remain in the low growth-low volume quadrant over the forecast period of 2018-2026, representing a sluggish 2.8% CAGR, predicts Persistence Market Research.

Uterine Cancer Diagnostic Testing Market – Persistence Market Research forecasts revenue in the global uterine cancer diagnostic testing market to reach around US$ 3.8 Bn by 2026 end, up from an estimated value of about US$ 2 Bn in 2018.

About Us:-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market ResearchAddress – 305 Broadway, 7th FloorNew York City,NY 10007 United StatesU.S. Ph. – +1-646-568-7751USA-Canada Toll-free – +1 800-961-0353Sales – sales@persistencemarketresearch.comWebsite – https://www.persistencemarketresearch.com